XML 21 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
SEGMENT INFORMATION
 9 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
SEGMENT INFORMATION
5.
SEGMENT INFORMATION
 
We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to the Consolidated Financial Statements in our annual report on Form 10-K for the fiscal year ended September 30, 2017.
 
 
 
Three Months Ended

‎
June 30,
 
 
Nine Months Ended

‎
June 30,
 
 
 
2018
 
 
2017
 
 
2018
 
 
2017
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Service
 
$
4,866
 
 
$
4,954
 
 
$
14,421
 
 
$
15,180
 
Product
 
 
1,173
 
 
 
882
 
 
 
2,939
 
 
 
3,189
 
 
 
$
6,039
 
 
$
5,836
 
 
$
17,360
 
 
$
18,369
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating Income
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Service
 
$
126
 
 
$
512
 
 
$
554
 
 
$
1,253
 
Product
 
 
(158
)
 
 
(175
)
 
 
(465
)
 
 
(267
)
 
 
$
(32
)
 
$
337
 
 
$
89
 
 
$
986
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 
(49
)
 
 
(112
)
 
 
(149
)
 
 
(332
)
Other income
 
 
1
 
 
 
2
 
 
 
5
 
 
 
4
 
Income (loss) before income taxes
 
$
(80
)
 
$
227
 
 
$
(55
)
 
$
668